The Role of Biosimilars in Uveitis: Long-Term Real-World Outcomes of the Switch From Original to Biosimilar TNF-Alpha Inhibitors
Background: Recent expiry of patents for tumor necrosis factor (TNF)-α inhibitors has led to the employment of biosimilars in clinical practice. The aim of the study was to identify any change in the control of ocular inflammatory manifestations among patients with non-infectious uveitis switching f...
Saved in:
Main Authors: | Claudia Fabiani (Author), Antonio Vitale (Author), Giacomo Emmi (Author), Arianna Sgheri (Author), Giuseppe Lopalco (Author), Jurgen Sota (Author), Silvana Guerriero (Author), Florenzo Iannone (Author), Bruno Frediani (Author), Lorenzo Vannozzi (Author), Maria Teresa Bianco (Author), Valtere Giovannini (Author), Gian Marco Tosi (Author), Luca Cantarini (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience
by: Jurgen Sota, et al.
Published: (2020) -
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study
by: Alice Bitossi, et al.
Published: (2019) -
New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy
by: Claudia Fabiani, et al.
Published: (2020) -
Biosimilar Use and Switching in Belgium: Avenues for Integrated Policymaking
by: Liese Barbier, et al.
Published: (2022) -
Switching Among Biosimilars: A Review of Clinical Evidence
by: Eleonora Allocati, et al.
Published: (2022)